A F Lazarev Selected Research

nucleolar organizer region associated proteins

11/2014	Relationship of argyrophilic proteins of nucleolal organizer regions in Ki-67+ cells with clinical and morphological parameters in lung adenocarcinoma.
9/2014	Argyrophilic proteins of nucleolar organizer regions and proliferative activity of cells in squamous cell carcinoma of the lung.
11/2013	Relationship between the argyrophilic proteins of the nucleolar organizer region and stage of squamous-cell carcinoma of the lung.
7/2010	[Argyrophilic nucleolar organizer region associated proteins in adenomas with varying colonic dysplasia and adenocarcinoma].
5/2008	[The morphofunctional characteristics of proteins of nucleolar organizers in uterine smooth muscle tumors].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A F Lazarev Research Topics

Disease

19	Neoplasms (Cancer) 10/2016 - 11/2002
5	Smooth Muscle Tumor 12/2015 - 05/2008
5	Leiomyoma (Uterine Fibroids) 01/2011 - 05/2008
4	Breast Neoplasms (Breast Cancer) 10/2016 - 07/2009
3	Neoplasm Metastasis (Metastasis) 09/2014 - 01/2008
3	Leiomyosarcoma 01/2011 - 07/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2015 - 10/2014
2	Adenocarcinoma of Lung 11/2014 - 01/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2014 - 11/2013
2	Adenocarcinoma 07/2010 - 11/2002
1	Prostatic Neoplasms (Prostate Cancer) 07/2014
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2014
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 11/2013
1	Surgical Blood Loss 01/2012
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2010
1	Adenoma (Adenomas) 07/2010
1	Mesothelioma 01/2008
1	Carcinoma (Carcinomatosis) 01/2008
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2007

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 03/2015 - 11/2002
5	nucleolar organizer region associated proteinsIBA 11/2014 - 05/2008
3	Ki-67 Antigen (Ki 67 Antigen)IBA 11/2014 - 01/2014
3	Estrogens (Estrogen)FDA Link 02/2014 - 07/2009
3	EnzymesIBA 02/2014 - 01/2011
2	AntibodiesIBA 10/2016 - 01/2008
2	Progesterone FDA LinkGeneric 01/2011 - 07/2009
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2011 - 01/2010
1	Peptides (Polypeptides)IBA 10/2016
1	AntigensIBA 10/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	ArginaseIBA 01/2016
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2015
1	Silver NitrateIBA 11/2014
1	AntioxidantsIBA 07/2014
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 02/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2014
1	Interleukin-2 (IL2)IBA 01/2014
1	recombinant FVIIa (rFVIIa)FDA Link 01/2012
1	Factor VIIa (Activated Factor VII)IBA 01/2012
1	Bromodeoxyuridine (BrdU)IBA 01/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2010
1	Estrogen Receptor alphaIBA 01/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2010
1	DNA (Deoxyribonucleic Acid)IBA 07/2009
1	Glutathione Transferase (Glutathione S-Transferase)IBA 07/2009
1	VimentinIBA 01/2008
1	ThrombomodulinIBA 01/2008
1	MesothelinIBA 01/2008
1	Calbindin 2IBA 01/2008
1	A-factor (Streptomyces)IBA 01/2007

Therapy/Procedure

2	Radiotherapy 01/2014 - 01/2007
2	Adjuvant Chemotherapy 01/2007 - 11/2002
1	Immunotherapy 01/2014
1	Combination Drug Therapy (Combination Chemotherapy) 01/2007
1	Catheters 01/2007